SIRT5 deficiency enhances the proliferative and therapeutic capacities of adipose‐derived mesenchymal stem cells via metabolic switching

BACKGROUND: Mesenchymal stem cells (MSCs) have therapeutic potential for multiple ischemic diseases. However, in vitro expansion of MSCs before clinical application leads to metabolic reprogramming from glycolysis to oxidative phosphorylation, drastically impairing their proliferative and therapeuti...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Transl Med
Autors principals: Ou, Tiantong, Yang, Wenlong, Li, Wenjia, Lu, Yijing, Dong, Zheng, Zhu, Hongming, Sun, Xiaolei, Dong, Zhen, Weng, Xinyu, Chang, Suchi, Li, Hua, Li, Yufan, Qiu, Zhiwei, Hu, Kai, Sun, Aijun, Ge, Junbo
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7510333/
https://ncbi.nlm.nih.gov/pubmed/32997407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ctm2.172
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars